BEAM
Asset Logo

Beam Therapeutics Inc

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 6.14%
Annual Growth

5 years average annual growth

🌏

2
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy. ESCAPE is a potentially non-genotoxic approach to HSC transplantation. BEAM-302 is a liver-targeting lipid nanoparticle formulation of base editing reagents. BEAM-201 is an anti-CD7 CAR-T product candidate.

📈 Performance

Price History*

+29.44%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$23.60

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in BEAM

2

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

50 weeks

💵 Average investment amount

$675

Last time a customer invested in BEAM

794 days
BEAM investor breakdown
💵 Income of investors

More than 200k

150k - 200k

50%

100k - 150k

50k - 100k

50%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

50%

35 - 90

50%
🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in BEAM also invest in...

Microsoft Corporation

MSFT

🙌 Performance (5Yr p.a)

35.25%

📊 Share price

$412.87 USD

📈 HIGH PRICE GROWTH

Find Out More

🙌 Performance (5Yr p.a)

-17.56%

📊 Share price

$1.00 USD

🙌 Performance (5Yr p.a)

-12.64%

📊 Share price

$0.32 USD

🙌 Performance (5Yr p.a)

6.29%

📊 Share price

$6.25 USD

🙌 Performance (5Yr p.a)

-11.31%

📊 Share price

$2.32 USD

Want more shares? Try these...

📊 Share price

$2.83 USD

📊 Share price

$10.00 USD
Compare
Add to watchlist